Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Medidata eCOA
Best for
Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform
What to consider
Medidata eCOA lists 2,500+ COAs, 200+ languages and dialects and 1,600+ studies, and data flows straight into Rave EDC. Study builders can configure it in Medidata Designer, with an average study start of 8 weeks. Prices are not published.
Clinical trials and research studies where ongoing participant engagement is central, with electronic assessments, reminders and follow-up in one study app
What to consider
WeGuide combines electronic outcome assessments with ongoing participant engagement for clinical trials and research studies. Teams connect assessments with consent, reminders and follow-up in a branded study app, with multilingual and wearable-data options. This supports study designs that need participants to stay involved between visits or over time, including investigator-led studies, cohorts and registries. Suitability depends on the assessments and workflows required, rather than study size alone. Confirm instrument licensing, assessment validation and any intensive site-entry or device-logistics needs.
Less suitable for
Protocols requiring a fully managed global provisioned-device fleet or an enterprise EDC and drug-supply suite from the same provider; confirm the required capture modes and services.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Medidata eCOA vs WeGuide (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Medidata eCOA
WeGuide
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Medidata eCOA
Extended support
2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service.
A reusable instrument library is paired with a validated instrument license-management service.
WeGuide
Supported
WeGuide publishes an assessment-instrument library and describes instrument licensing and digital-migration support. Confirm permissions and validation responsibilities for each chosen instrument.
Outcome forms and licensing support are described; confirm author approval and the managed licensing scope for each selected instrument before assuming the extended definition is met.
Regulatory compliance and track recordFeature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Medidata eCOA
Supported
Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published.
Part 11, Annex 11 and ICH E6 statements are documented; the approval claim is company-wide.
WeGuide
Supported
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
Languages and study volumes are documented; this note does not establish multicountry use.
WeGuide
Extended support
WeGuide describes BRACE across five countries and INHERIT in ten languages. These are examples of participant outcome collection, rather than a claim of enterprise-scale eCOA deployment.
BYOD, provisioned devices and Rave data flow are documented; listing Sensor Cloud does not establish sensor integration.
WeGuide
Supported
Electronic participant outcome forms connect to existing EDC systems through the Integration Engine. Provisioned-device fleet delivery is not established by this source.
Electronic capture and system connections are documented; the source does not establish provisioned-device fleet support.
Time to launch and self-service buildFeature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Medidata eCOA
Extended support
Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard.
Team-configurable study workflows and a stated configuration timeframe meet the same launch definition applied to other products.
Published pricing and termsFeature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Medidata eCOA
Supported
No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees.